Article History
Accepted: 18 April 2023
First Online: 30 May 2023
Compliance with Ethical Standards
:
: Simon Wu declares that he has no conflict of interest. Piers Blombery has received honoraria from Adaptive Biotechnologies, AstraZeneca and Servier. David Westerman has served as a consultant for Pfizer Australia. Constantine Tam has served as a consultant for AbbVie and AstraZeneca, and has received honoraria from AbbVie, BeiGene and Janssen.
: This article does not contain any studies with human or animal subjects performed by any of the authors.